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Abstract
We investigated the vision-related quality of life (VR-QOL) and the prevalence and severity of depression in patients with
herpetic anterior uveitis (AU). This study was conducted in 2012 at the ophthalmology department of the University Medical
Center of Groningen (tertiary referral center). We selected patients from an existing uveitis database, all eligible patients
were approached. Thirty-six of 66 (55%) patients with herpetic AU (herpes simplex virus or varicella zoster virus)
participated, patients were 18 years or older. The diagnosis was made by clinical presentation or a positive anterior chamber
tap. All patients received an information letter, informed consent form, National Eye Institute Visual Functioning
Questionnaire-25 (NEI VFQ-25), Beck Depression Inventory (BDI-II), Social Support List – Interactions (SSL-I), Social Support
List – Discrepancies (SSL-D) and an additional questionnaire for gathering general information. Medical records were
reviewed for clinical characteristics. Analyses were conducted on various patient and ocular characteristics. We compared
our NEI VFQ-25 scores with those previously found in the literature. Our main outcome measures were VR-QOL, prevalence
and severity of depression, social support and various patient and ocular characteristics that could influence the VR-QOL.
We found that the NEI VFQ-25 mean overall composite score (OCS) was 88.1610.6. Compared with other ocular diseases our
OCS is relatively high, but lower than that found in a normal working population. The mean general health score was
59.0619.0; this score is lower than in patients with other ocular diseases, except for untreated Behc¸et’s patients. Depression
was scarce, with only one patient (2.8%) having a moderate depression (BDI-II score of 21). We concluded that herpetic AU
affects the VR-QOL in a moderate way. The prevalence of depression in our group of herpetic AU patients was low and
therefore does not seem to indicate a need for specific screening and intervention measures in these patients.
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Introduction
Anterior uveitis (AU) is the predominant form of uveitis and
herpetic AU is the most frequently observed form of infectious
AU. [1] Characteristics like dermatitis, keratitis, elevated intraoc-
ular pressure (IOP) and iris sector atrophy are seen in herpetic AU.
[2] Also secondary complications, like glaucoma and cataract are
reported. [3] Complications of uveitis can lead to irreversible loss
of visual functioning. [4] Previous studies showed that 35% of
uveitis patients in the Western society are significantly visually
impaired or blind [5].
Uveitis is seen in all age groups, and a substantial proportion of
patients is of working age. During active uveitis, the inflammation
and its treatment may – temporarily – affect visual functioning in
such a way that it interferes with reading, computer work, driving,
etc. Some patients may lose their job because of – recurrent –
uveitis. Fear of a recurrence may cause increased stress levels, even
when the uveitis is quiet. This may result in a decreased vision-
related quality of life (VR-QOL) and an increased risk of
developing a depression.
The purpose of this study is to evaluate the VR-QOL and the
prevalence and severity of depression in a group of patients with a
specific type of uveitis, i.e. herpetic AU (including herpes simplex
virus (HSV) or varicella zoster virus (VZV) related AU). Previous
research on a large group of uveitis patients found that uveitis
patients reported a markedly poorer visual functioning and general
health status than healthy subjects. [6] That study evaluated a
non-homogeneous group of uveitis patients with different causes
and manifestations of the disease. Since each cause and
manifestation of uveitis may differ with regard to clinical
characteristics and residual symptoms, it would also be of interest
to examine the VR-QOL in the different uveitis entities separately.
This may give valuable information for entity-related counseling of




The Medical Ethical Committee of the University Medical
Center of Groningen ruled that approval was not required for this
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study. The study was conducted according to the tenets of the
Declaration of Helsinki.
Patients
The patients included in this study were selected from an
existing database, containing uveitis patients who had been treated
or are currently being treated for uveitis at the ophthalmology
department of the University Medical Center of Groningen, which
is a tertiary referral center. We included 66 patients with herpetic
AU. All patients were 18 years or older. The diagnosis was made
by clinical presentation (keratitis - dendritic herpes branch -
followed by AU, elevated intraocular pressure at presentation, iris
sector atrophy developing over time and/or clear facial varicella
zoster infection (ophthalmic nerve) with subsequent kerato-uveitis)
or a positive anterior chamber tap for local antibody production or
the presence of virus DNA by PCR. Patients with other forms or
possible causes of uveitis were excluded.
Data
All 66 patients received an information letter and an informed
consent form by mail. Included in this letter, they received the
following questionnaires; the National Eye Institute Visual
Functioning Questionnaire-25 (NEI VFQ-25), the Beck Depres-
sion Inventory (BDI-II), Social Support List – Interactions (SSL-I),
Social Support List – Discrepancies (SSL-D) and an additional
questionnaire for gathering general information. The patients
were asked to complete the questionnaires at home, to sign the
informed consent form and to return them by mail.
For measuring the VR-QOL, we used the validated Dutch
version of the NEI VFQ-25. The NEI VFQ-25 has been
developed by the National Eye Institute. This validated [7,8]
self-administered questionnaire consists of 25 questions, with a
total score and subscores ranging from 0–100. In this question-
naire, the score of 0 corresponds to the lowest and of 100 to the
highest VR-QOL. There are 12 subscales, each consisting of one
or more questions. These subscales are general health, general
vision, ocular pain, near activities, distance activities, vision
specific social functioning, vision specific mental health, vision
specific role difficulties, vision specific dependency, driving, color
vision and peripheral vision.
The BDI-II is a validated [9] self-administered questionnaire
consisting of 21 questions on how the patient feels and experiences
things. Each question can be answered on a four-point scale
ranging from 0 to 3. Subscores are added to create a total score. A
total score of 0 to 13 corresponds with no depression, of 14 to 19
with a mild depression, of 20 to 28 with a moderately severe
depression and of 29 to 63 with a severe depression. The SSL-I
and SSL-D are questionnaires developed and validated by the
University of Groningen (RUG). These questionnaires measure (1)
social interactions between patients and persons with whom they
interact and (2) if the received social support corresponds with the
desired social support. They each consist of 34 four-choice
questions, resulting in scores ranging from 1–4. A high SSL-I score
corresponds with sufficient social support. A high SSL-D score
corresponds with a deficiency in desired social support. The
maximum score of the SSL-I is 136 and of the SSL-D it is 102.
The following information was gathered by the additional
questionnaire: present activity of the uveitis, presence of other
chronic diseases or diseases with a large impact (recent or in the
past), medication use (ocular and other medication), history of
depression and/or treatment, and need for visual revalidation. By
reviewing medical records, we gathered the following information:
present age, sex, unilateral or bilateral AU, systemic disease,
follow-up time (defined as time between the start of the first uveitis
episode and the end of the last uveitis episode), total time of active
disease, total number of uveitis episodes, remission time (defined as
time between the end of the last uveitis episode and the date on the
questionnaire), Snellen visual acuity (VA), ocular complications in
history (elevated IOP, glaucoma, cataract, secondary cataract,
keratitis, dry eyes, cystoid macular edema (CME), papillitis,
scleritis and herpes zoster ophthalmicus (HZO)) and presence of
active uveitis at the time of completing the questionnaire.
Active uveitis was defined as $0.5+ cells in the anterior
chamber. [10] Transiently elevated IOP was defined as a
measured IOP.20 mmHg without pressure reducing medication.
Glaucoma was defined as the presence of visual field defects typical
for glaucoma that were reproducible and could not be explained
by other pathology, with or without glaucomatous disc abnormal-
ities. Dry eyes were defined as the presence of dry eye symptoms
and need for artificial tears.
Statistics
Data were statistically analyzed using SPSS Statistics 20.0.0.1.
For the comparison of continuous variables of two groups, we used
the Mann-Whitney U test. For comparison of continuous variables
of more than two groups, we used the Kruskal–Wallis one-way
analysis and the Mann-Whitney U test for post hoc analysis with a
Bonferroni correction, using a critical value of 0.05 divided by the
number of tests conducted. Correlations were assessed with the
Spearman’s Rank Correlations test. For analyzing, Snellen VA
was converted to the logarithm of the minimum angle of resolution
(logMAR) equivalent. Statistical significance level was set at 0.05.
Results
Thirty-six of 66 (55%) patients participated by filling out the
questionnaires and returning them by mail. Table 1 summarizes
the clinical characteristics of the 27 HSV and nine VZV AU
patients. Males were slightly overrepresented in relation to females
(58 versus 42%). Mean age of the HSV patients was 55.7617.5
years and of VZV patients it was 63.7615.1 years (p = 0.201).
Complications most frequently observed (in % of patients) were
elevated IOP (69%), keratitis (64%), dry eyes (42%) and cataract
(36%). We checked and confirmed that all complications
developed after the diagnosis of AU. The mean (6 SD) of the
NEI VFQ-25, BDI-ll, SSL-I and SSL-D scores are given in
Table 1. Only one patient had a moderate depression (BDI-II
score of 21) at the time of completing the questionnaires, for which
he already received medical treatment.
Tables 2 and 3 give information on the mean (6 SD) of the
overall composite score (OCS) and the subscales of the NEI VFQ-
25 in the total group. Also, differences herein related to various
patient characteristics and ocular variables are presented. The
mean OCS in the total group was 88.1610.6 and the mean
general health score was 59.0619.0.
Female patients scored significantly lower on ocular pain
(indicating that they experienced more pain or discomfort around
or in the eye). VZV patients scored lower on all subscales and on
the OCS compared to HSV patients, but only the difference in
scores on vision specific mental health reached significance.
Patients with active uveitis had significantly lower vision specific
social functioning and vision specific dependency scores. They also
had lower distance activities scores, but this did not reach
significance. Patients who experienced just one uveitis episode had
significantly lower ocular pain scores (more pain) than patients
who experienced multiple uveitis episodes. Dry eye patients scored
significantly lower on ocular pain (more pain) and on the OCS.
Patients with transiently or persistently elevated IOP had
Quality of Life in Herpetic Uveitis
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significantly lower distance activities scores. Patients with a Snellen
VA of less than 0.5 in at least one eye, scored lower on the OCS
and on all subscales, but only the scores on general vision, near
activities and peripheral vision reached significance.
Age, keratitis and uveitis treatment showed no significant
correlation with any of the NEI VFQ-25 outcomes. Also, patients
with or without other chronic diseases (in our group: diabetes,
respiratory diseases, hypercholesterolemia, hypertension and back
pain) or diseases with a large impact (in our group: multiple brain
infarcts, cancer, psoriasis vulgaris, depression, antithrombin III
deficiency, polymyalgia-rheumatica, hypothyroidism and cardio-
vascular diseases (recent or in the past)) did not score significantly
different on the NEI VFQ-25 scales, including the general health
subscale.
Table 4 shows the results of the Spearman’s Rank Correlations
tests between studied variables and NEI VFQ-25 subscale scores
and OCS. Age at completing the questionnaire and general vision,
near activities and vision specific role difficulties were negatively
correlated. LogMAR VA of the uveitic eye was negatively
correlated with near activities and peripheral vision. Remission
time was positively correlated with peripheral vision and central
vision. The BDI score was negatively correlated with general
health, vision specific social functioning, vision specific mental
health, vision specific role difficulties, vision specific dependency,
driving and OCS. There was no significant correlation between
the subscale scores and OCS and logMAR VA of the healthy eye,
duration of active uveitis, total of uveitis episodes, follow-up time,
SSL-I score and SSL-D score. There was no significant correlation
between the BDI-II score and the SSL-I score or the SSL-D score.
Discussion
We found that in general NEI VFQ-25 subscale scores and the
OCS were reasonably high in herpetic AU patients. We found a
mean OCS of 88.1 which means that the majority of patients
scored between the best possible (100.0) and the second best score
(75.0). General health is the only subscale that is not included in
the OCS. The mean general health score was lower than the
means of the other subscales, namely 59.0. However, this still
means that the majority of patients scored their general health
between ‘good’ (50.0) and ‘very good’ (75.0). Depression was
scarce in our study group, with only one patient having a
moderate depression.
To give an overall idea of the height of the scores in our patient
group in relation to those previously found in healthy persons and
in patients with ocular disease, we constructed Table 5. Interest-
ingly, Hirneiss et al. who obtained NEI VFQ-25 scores in a
normal working population as well as in subpopulations thereof
with and without ocular disease, found that general health scores
were lower in the subgroup with ocular disease. [11] The general
health scores of his total group and subpopulations were higher
than in our patient group. Studies on patients with noninfectious
ocular inflammatory disease and Birdshot chorioretinopathy
showed general health scores comparable with our general health
score. [12,13] Highest general health scores were achieved in
patients with acute posterior vitreous detachment. [14] Untreated
Behc¸et’s disease patients had the lowest general health scores,
which is not surprising because of the commonly associated
systemic manifestations in this entity [15].
The overall composite score (OCS) is low in untreated Behc¸et’s
disease and Birdshot chorioretinopathy. [13,15] Unfortunately,
OCS was not given in the study on bilateral age-related macular
degeneration patients, but from the subscale scores, it can be
derived that it will have been lowest in this patient group. [16]
Schiffman et al. also found a relatively low OCS (663.0) in a large
group of uveitis patients. Their data was presented graphically and
therefore it is difficult to derive exact values on NEI VFQ-25
scores. Because of this, we did not include that study in Table 5.
[6] In our patient group, OCS was relatively high, but lower than
those in the working population and in acute posterior vitreous
detachment patients. [11,14] A possible explanation for the
relatively high OCS in our study is that all our patients had a
unilateral disease.
Looking at subgroup analyses in our study group (Tables 2, 3
and 4), age at the moment of completing the questionnaires
seemed to be of no influence on total NEI VFQ-25 scores. When
evaluating correlations between age and the NEI VFQ-25
subscales, it seems that general vision, near vision and performing
tasks nearby become more difficult with age. Also, older patients
more often indicate that accomplishing things is getting more
difficult because of reduced vision and they feel limited because of
their vision. Surprisingly, a history of keratitis seemed to have no
effect on VR-QOL, whereas we would expect that residuals of
Table 1. Clinical characteristics of herpetic AU patients and
overall scores on questionnaires (N and (%) or Mean 6 SD
(range)).
Number of patients 36
HSV/VZV 27 (75%)/9 (25%)
Female/male 15 (42%)/21 (58%)
Unilateral/bilateral 36 (100%)/0 (0.0%)
Age at completing questionnaire (yrs) 57.7617.1 (25–88)
Follow-up time (yrs) 8.7612.4 (0.04–41.3)
Number of uveitis episodes 4.765.4 (1–27)
Time of active uveitis (months) 5.164.3 (1–17)
Remission time (yrs) 3.662.5 (0.02–10.7)
Depression in pasta 4 (11%)
Complicationsb
- Elevated IOP 25 (69%)
- Keratitis 23 (64%)
- Dry eyesc 15 (42%)
- Cataract 13 (36%)
- HZO 8 (22%)
- Glaucoma 5 (14%)
- Secondary cataract 4 (11%)
- CME 2 (6%)
- Scleritis 0 (0%)
- Papillitis 0 (0%)
NEI VFQ-25 OCSd 88.1610.6 (51.7–97.6)
BDI-II score 3.764.5 (0–21)
SSL-I score 74.0617.8 (34–105)
SSL-D score 45.3616.1 (34–102)
AU: anterior uveitis, HSV: Herpes Simplex Virus, VZV: Varicella Zoster Virus, IOP:
Intraocular Pressure, CME: Cystoid Macular Edema, HZO: Herpes Zoster
Ophthalmicus, OCS: Overall Composite Score, BDI: Beck Depression Inventory,
SSL-I: Social Support List - Interactions, SSL-D: Social Support List -
Discrepancies.
aDiagnosed by a physician and medically treated.
bDeveloped during follow-up AU.
cMedication needed.
dAverage of vision-targeted subscale scores, without general health subscore.
doi:10.1371/journal.pone.0085224.t001
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keratitis would influence visual functioning and thereby some of
the vision related subscales of the NEI VFQ-25. Also, any medical
chronic condition or medical condition (other than ophthalmo-
logic) with a large impact seemed to have no influence on the NEI
VFQ-25 scores. Our study and studies summarized in Table 5
seem to suggest that ophthalmic disease itself may influence
general health scores.
In our study, significantly more pain or discomfort in or around
the eye was reported by female patients and patients who
experienced only one uveitis episode. Previous clinical and
epidemiological studies show that women are at an increased risk
of developing chronic pain and some evidence suggests that
women may experience more severe pain. Multiple biopsychoso-
cial mechanisms may contribute to these gender differences in
experienced pain, including sex hormones, endogenous opioid
function, genetic factors, pain coping and catastrophizing and
gender roles. [17] A possible explanation for the difference in
reported pain between patients with one versus multiple uveitis
episodes, could be the fact that herpes viruses are neurotrophic,
and can destroy sensible nerve fibers. This is well-known for
corneal sensibility [18] but may also apply to other structures
within the eye. Presumably, repeated herpes activity will have a
cumulative effect. Another possibility is that coping strategies may
change with a longer duration of the disease.
VZV patients scored somewhat lower on all subscales and OCS
compared with HSV patients, and this was not due to age or VA.
Eight out of nine (89%) VZV patients had had HZO, and it is
therefore possible that the lower scores are at least partly due to
the occurrence of dermatitis or post-herpetic neuralgia in these
patients. Lukas et al. showed that herpes zoster, and especially
post-herpetic neuralgia, is associated with increased levels of pain
that have a significant impact on QOL scores. [19] In our study,
dry eye patients had a lower OCS, which was mainly due to more
ocular pain. Li et al. also reported that VR-QOL in dry eye
patients can be impaired [20].
Patients with a Snellen VA of less than 0.5 in at least one eye,
were more likely to have lower VR-QOL scores, compared to
patients with a Snellen VA of more than 0.5 at both eyes. Of these,
only the scores on the subscales general vision, near activities and
peripheral vision reached significance. The VA of the uveitic eye
was correlated with near activities and peripheral vision scores
(Table 4). The VA in the fellow eye does not seem to have any
influence on the VR-QOL. The fact that we did not find major
significant differences based on VA, was possibly due to the fact
that most patients had a relatively good VA in both eyes.
In our study, we identified only one patient (2.8%) with a
moderate depression. By comparison, de Graaf et al. found a
12–month prevalence of any mood disorder (i.e. depression and
other mood disorders) of 6.1% in the Netherlands between 1996
and 2009. [21] Qian et al. reported that 28/104 (26.9%) of
patients with ocular inflammatory disease screened positive for
depression, using the BDI-II questionnaire. These depressed
patients scored far lower on the composite VFQ-25 score than
non-depressed patients. [12] In our study, patients with a higher
BDI-II score were also likely to score lower on the VR-QOL.
We found that a higher BDI-II score was negatively correlated
with general health, vision specific social functioning, vision
specific mental health, vision specific role difficulties, vision
specific dependency, driving and OCS. A possible explanation
for the higher prevalence of depression in the study of Qian
et al., is that they included patients with severe posterior and
panuveitis in addition to AU patients. Qian et al. also mention
that inadequate emotional support is a predictor of depression.
In our study, the amount of social support appeared to have no
influence on VR-QOL or depression.
The main shortcoming of our study is its modest sample size.
Our sample size is considered adequate for overall analyses [22],
but it may be too limited for all subgroup analyses, resulting in an
underreporting of possibly relevant associations. Also, only 55% of
herpetic uveitis patients participated in the present study, which
may have resulted in a selection bias. Furthermore, our patients
were seen at a tertiary referral center and therefore this population
may not represent the general uveitis population.
In conclusion, herpetic AU affects the VR-QOL, but only in a
moderate way. The NEI VFQ-25 subscale scores and OCS are
reasonably good. The prevalence of depression in our group of
herpetic AU patients was low and therefore does not seem to
indicate a need for specific screening and intervention measures in
this specific patient group.
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